Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Clinical and Translational Radiation Oncology
|
December 1, 2022
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer
David J Thomson, Clare Cruickshank, Helen Baines, et al.
Cancer Discovery
|
April 29, 2017
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition
Jane Goodall, Joaquin Mateo, Wei Yuan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 2019
A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations
Sally L George, Elisa Izquierdo, James Campbell, et al.
Nature Medicine
|
July 4, 2018
Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells
Mara Vinci, Anna Burford, Valeria Molinari, et al.
The Lancet. Oncology
|
December 7, 2019
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
Joaquin Mateo, Nuria Porta, Diletta Bianchini, et al.
Science Translational Medicine
|
October 9, 2024
A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis
Rong Li, Michela Colombo, Guanlin Wang, et al.
Cancer Discovery
|
November 5, 2021
DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition
Elisa Izquierdo, Diana M Carvalho, Alan Mackay, et al.
Cancer Research
|
November 10, 2021
HER3 Is an Actionable Target in Advanced Prostate Cancer
Veronica Gil, Susana Miranda, Ruth Riisnaes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 10, 2025
The spectrum of IDH- and H3-wildtype high-grade glioma subgroups occurring across teenage and young adult patient populations
Rita Pereira, Alan Mackay, Yura Grabovska, et al.
Neuro-Oncology Advances
|
March 30, 2026
Characterization of patient-derived site-specific <i>in vivo</i> models of pediatric-type diffuse high-grade glioma using magnetic resonance imaging
Jessica K R Boult, Diana M Carvalho, Ketty Kessler, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Clinical and Translational Radiation Oncology
|
December 1, 2022
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer
David J Thomson, Clare Cruickshank, Helen Baines, et al.
Cancer Discovery
|
April 29, 2017
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition
Jane Goodall, Joaquin Mateo, Wei Yuan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 2019
A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations
Sally L George, Elisa Izquierdo, James Campbell, et al.
Nature Medicine
|
July 4, 2018
Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells
Mara Vinci, Anna Burford, Valeria Molinari, et al.
The Lancet. Oncology
|
December 7, 2019
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
Joaquin Mateo, Nuria Porta, Diletta Bianchini, et al.
Science Translational Medicine
|
October 9, 2024
A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis
Rong Li, Michela Colombo, Guanlin Wang, et al.
Cancer Discovery
|
November 5, 2021
DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition
Elisa Izquierdo, Diana M Carvalho, Alan Mackay, et al.
Cancer Research
|
November 10, 2021
HER3 Is an Actionable Target in Advanced Prostate Cancer
Veronica Gil, Susana Miranda, Ruth Riisnaes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 10, 2025
The spectrum of IDH- and H3-wildtype high-grade glioma subgroups occurring across teenage and young adult patient populations
Rita Pereira, Alan Mackay, Yura Grabovska, et al.
Neuro-Oncology Advances
|
March 30, 2026
Characterization of patient-derived site-specific <i>in vivo</i> models of pediatric-type diffuse high-grade glioma using magnetic resonance imaging
Jessica K R Boult, Diana M Carvalho, Ketty Kessler, et al.
Page
of 7